Skip to main content

Table 1 Patient characteristics and pathological/clinical findings

From: Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients

Patient

Gender

Age at diagnosis

Primary site

Histology

Type of surgery (R0/R1/R2)

Years first relapse

Pattern of relapse

First relapse surgery

Histology

Years second relapse

Pattern of relapse

Second relapse surgery

Histology

Status last FU

1

M

52

pelvis

MSFT

R1

10y

local

Y

MSFT

2y

local

Y

MSFT

DOD

2

M

28

head and neck

MSFT

R1

12y

mts

N

MSFT*

1y

mts

N

NA

DOD

3

M

48

pleura

NA

R1

11y

mts

N

MSFT*

1y

mts

N

NA

LFU

4

M

31

pelvis

MSFT

R1

10y

local

Y

MSFT

0y

local

Y

MSFT

AWD

5

M

61

pelvis

MSFT

R1

11y

local

Y

MSFT

2y

mts

N

MSFT*

DOD

6

F

36

pleura

SFT

R1

10y

local

Y

MSFT

3y

local

Y

MSFT

LFU

7

F

66

pelvis

MSFT

R1

11y

local

Y

MSFT

1y

mts

N

MSFT*

LFU

8

F

27

head and neck

MSFT

R1

16y

local

Y

MSFT

11y

local

Y

MSFT

AWD

9

F

46

retroperitoneum

SFT

R1

13y

mts

N

PDSFT*

1y

mts

N

NA

DOD

10

F

53

pleura

SFT

R1

12y

local + mts

N

MSFT*

1y

local

N

NA

AWD

11

M

41

pleura

MSFT

R1

20y

local

Y

MSFT

1y

local

N

NA

LFU

12

M

43

pleura

SFT

R1

13y

local

Y

MSFT

1y

local

N

NA

DOD

13

M

58

head and neck

SFT

R1

10y

local

Y

MSFT

6y

mts

Y

MSFT

DOD

14

M

41

retroperitoneum

NA

R1

23y

local

N

MSFT*

1y

mts

N

MSFT*

DOD

  1. *Histological diagnosis was performed by FNAC.
  2. SFT, typical solitary fibrous tumor; MSFT, malignant solitary fibrous tumor; PDSFT, pleomorphic/dedifferentiated solitary fibrous tumor.
  3. NA, not assessed; DOD, dead of disease; LFU, lost to follow-up; AWD, alive with disease.